ReviewCancer management and research2026
lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms.
Review in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The long non-coding RNA (lncRNA) HOTAIR (HOX transcript antisense RNA) has emerged as an important regulatory molecule that plays a critical role in tumor initiation and progression. With advances in tumor molecular biology, HOTAIR has become a research focus owing to its high expression in multiple malignancies and its profound impact on key biological behaviors such as tumor cell proliferation, migration, invasion, and drug resistance. This review critically synthesizes recent advances, with a focus on mechanistic controversies, context-dependent functions, and the integration of epigenetic, non-coding RNA, and signaling network mechanisms. Current studies indicate that HOTAIR regulates diverse cellular functions and drives tumor progression mainly through epigenetic modification, modulation of key signaling pathways, and complex interactions with microRNAs (miRNAs). However, its precise molecular mechanisms have not yet been fully elucidated, and translation into clinical practice remains challenging. This review summarizes recent progress on HOTAIR in cancer, systematically outlines its multifaceted molecular mechanisms and functions, and discusses its potential as a diagnostic biomarker and therapeutic target, with the aim of providing a theoretical basis and research directions for precision diagnosis and treatment in oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.